Pricing Log in Create free account
Friday 6 November 2026 Export LH’s income statement to Excel — free account

Labcorp Holdings Inc.

LH Healthcare Diagnostics & Research

Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024.

Revenue
+6.92%
EPS
+3.18%
Free cash flow
+44.7%
Total debt
+3.21%

Quarter to September 2026, against a year earlier

362.86 0.44 −0.12%
Market cap
$29.5B
P/E
29.5×
Fwd P/E
26.7×
Dividend yield
0.79%
F-score
8/9
Altman Z
3.02
Beneish M
−2.55
Dividend safety
74/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Labcorp Holdings Inc. 8-K filed Nov 4, 2026

Period ended Nov 4, 2026 · Filed · accepted 9:18 AM ET · Document on sec.gov · Filing index

7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits

What it says

Labcorp announced that Chief Financial Officer Julia Wang will speak at the UBS Global Healthcare Conference on November 10, 2026 at 8:45 a.m. ET. A live audio webcast of the fireside chat will be available at ir.labcorp.com and archived for replay for 180 days following the event.